<DOC>
	<DOCNO>NCT01079637</DOCNO>
	<brief_summary>Randomized clinical trial ( RCT ) compare treatment failure rate surgical arthrodesis MFB cast treatment patient suffer early stage Charcot neuroarthropathy ( CN ) midfoot ( Sella Barrette stag 0 , 1 2 ) within first 2 year initial treatment . Treatment failure define occurrence one following : 1 . Amputation , 2 . Occurrence ulcer worsen exist ulcer , 3 . Surgical intervention correction deformity initial treatment . The secondary aim compare foot function , radiologic outcome , quality life , complication foot temperature two group .</brief_summary>
	<brief_title>Midfoot Fusion Bolt ( MFB ) Early Stage Diabetic-neuropathic Charcot Feet</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Age &gt; 18 year Patients Diabetes Mellitus Type I II CN stag 0 , 1 2 midfoot ( Sella Barrette classification ) Willingness ability participate study followup accord protocol Ability understand read local language elementary level Signed informed consent Legal incompetence Previous Charcot foot affect side Active osteomyelitis affect foot Above knee amputation contralateral side Patient health status adequate surgery Active malignacy Severe peripheral arterial disease ( anklebrachial index &lt; 0.7 absent digital waveform Doppler ) Ulcer grade 2 Wagner classification system Alcohol drug abuse Lifethreatening comorbidities</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Sella Barrete Stage 0 1 2</keyword>
</DOC>